![]() |
|
|
1 Department of Pharmacology, University of Illinois, College of Medicine, Chicago, Illinois
Current evidence suggests that the 5-hydroxytryptamine (5-HT) present in the spinal cord is localized in the terminals of bulbospinal neurons and that the actions of 5-hydroxytryptophan (5-HTP), l-tryptophan and pargyline on spinal neuronal activity result from intraneuronal accumulations of 5-HT which overflows to activate receptors. If these postulates are correct, spinal cord 5-HT and the actions of 5-HTP, l-tryptophan and pargyline should be markedly diminished following section of the bulbospinal neurons. Assay of the lumbosacral cord of cats 3 weeks after a midthoracic cord transection revealed 5-HT values which were only 25% of the nontransected controls. Pargyline and l-tryptophan were without effect on the spinal reflexes in cats with chronic cord transection. These observations support the above conclusions. However, in chronic spinal cats 5-HTP still increased the monosynaptic spike height and depressed polysynaptic and dorsal root reflexes. Since the actions of 5-HTP were prevented by pretreatment with a decarboxylase inhibitor and reversed by a 5-HT antagonist, the actions of 5-HTP seem to be mediated by 5-HT. It thus appears that 5-HTP can be converted to 5-HT at sites other than descending bulbospinal neurons.
Submitted on February 14, 1968
This article has been cited by other articles:
![]() |
P. J. Harvey, X. Li, Y. Li, and D. J. Bennett 5-HT2 Receptor Activation Facilitates a Persistent Sodium Current and Repetitive Firing in Spinal Motoneurons of Rats With and Without Chronic Spinal Cord Injury J Neurophysiol, September 1, 2006; 96(3): 1158 - 1170. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Post, F. K. Goodwin, E. Gordon, and D. M. Watkin Amine Metabolites in Human Cerebrospinal Fluid: Effects of Cord Transection and Spinal Fluid Block Science, March 2, 1973; 179(4076): 897 - 899. [Abstract] [PDF] |
||||